Medical Devices

A new partnership between Beacon Biosignals and Project Sleep aims to dismantle the 11-year diagnostic delay for hypersomnia using at-home AI neurotechnology.

Enable Injections and Sanofi secure Japan’s first approval for an oncology on-body injector, shifting multiple myeloma treatment from the clinic to the consumer.

As sub-Saharan Africa battles a severe cervical cancer crisis, offline edge AI is stepping in where traditional labs fall short to bridge the diagnostic divide.

At the 2026 Collegiate Inventors Competition, a new wave of student-led medical technologies proves that impact matters more than consumer hype.

Sequel Med Tech’s twiist system just gained FDA clearance for type 2 diabetes, signaling a massive shift in how millions will manage their insulin therapy.

With positive Phase 3 data and an FDA review underway, a novel copper IUD aims to double its lifespan while navigating strict new provider safety mandates.

Despite passing legislation in 2020, Ontario has stalled on regulations that would mandate and track life-saving AEDs in schools. Tech integration is failing.

SpotitEarly's Bio-AI platform combines canine scent detection with machine learning to spot early-stage cancer. Will regulatory hurdles stall its 2027 launch?

As new MASH therapeutics hit the market, a strategic partnership between Echosens and Gastro Health signals a lucrative shift from liver biopsies to non-invasive, data-driven diagnostics.

CellTivity Scientific's Van Gogh system hits a major milestone, proving that real-time metabolic imaging is shifting from a niche tool to a surgical standard.

CMS approval for B. Braun's Stimuplex needles under the NOPAIN Act signals a major shift in how outpatient centers fund opioid-sparing pain management.

Centinel Spine just secured FDA two-level approval for its prodisc C Nova. Here is why tri-implant optionality is the end of one-size-fits-all spinal fusion.

Continuity Biosciences aims to eliminate the adherence burden of HIV PrEP with a multi-year nanofluidic implant, backed by the Gates Foundation.

Elion Therapeutics secures global rights to EL777, an inhaled antifungal aiming to prevent deadly infections in a growing immunocompromised population.

By putting pocket ultrasounds in medical students' hands, Butterfly Network isn't just selling hardware—it's building a lifetime subscription ecosystem.

Digital fitness enters the clinic. Future's new partnership with BodySpec bundles medical-grade DEXA scans to merge remote coaching with physical diagnostics.

As Myomo crosses the $40 million revenue threshold, the medical robotics firm brings in a heavy hitter to navigate Medicare and scale its bionic orthotics.

New real-world data reveals a 34% drop in hospitalizations for heart failure patients using CCM therapy, bridging a crucial gap in cardiac care economics.

Insulet's nationwide rollout of the Omnipod Discover platform signals a strategic shift in diabetes care, turning raw data into actionable clinical insights.

By bridging diagnostic testing with surgical simulation, Carrot’s latest acquisition signals a high-margin shift in how clinics manage the cataract pipeline.